Post by BioDuro

✨𝗦𝘁𝗶𝗹𝗹 𝗶𝗻 𝗕𝗮𝘀𝗲𝗹 — 𝘁𝗵𝗶𝘀 𝘁𝗶𝗺𝗲 𝗮𝘁 𝗕𝗢𝗦 𝟮𝟬𝟮𝟲✨ Working on a peptide-based therapeutic or a TPD? The chemical complexity doesn't stop at synthesis — it follows through formulation, scale-up, and every stage in between. Navigating all of that faster and right is what we are built for. That is exactly the kind of conversation we are here for at Booth 7. Small molecules are no exception: integrated DS and DP development from the start gets programs there faster and right, all the way from late-stage discovery into IND readiness and first-in-human studies.  If you are at BOS this week, stop by. We would love to talk. Schedule a meeting with our team: Ricardo Inacio, Anna Holderbaum https://lnkd.in/gETwD6qx #CMC #Peptide #DrugSubstance #DrugDevelopment #IND #BOSBasel2026